Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Anti-N-methyl-D-aspartate receptor encephalitis: a targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management.

Authors:
Jennifer L Kruse Jessica K Jeffrey Michael C Davis Joanna Dearlove Waguih W IsHak John O Brooks

Ann Clin Psychiatry 2014 May;26(2):111-9

Department of Psychiatry and Biobehavioral Sciences, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Background: Anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis was formally described in 2007 and includes a range of psychiatric and neurologic symptoms. Most patients with anti-NMDAR encephalitis initially present to psychiatrists for diagnosis and treatment. However, there is limited literature summarizing treatment strategies for psychiatric symptoms. In an effort to improve identification and treatment, this review article provides an overview of anti-NMDAR encephalitis, with a focus on psychopharmacologic treatment strategies. Two case reports provide a clinical context for the literature review.

Methods: The authors conducted a PubMed search.

Results: Prominent psychiatric symptoms of anti-NMDAR encephalitis include psychosis, agitation, insomnia, and catatonia. Neuroleptics may be helpful for managing psychosis and agitation, but may exacerbate movement abnormalities. Diphenhydramine and benzodiazepines are helpful for agitation and insomnia. In addition, the anticholinergic affinity of diphenhydramine can improve dystonia or rigidity attributable to anti-NMDAR encephalitis, while benzodiazepines and electroconvulsive therapy have been used for catatonia associated with this condition.

Conclusions: Psychiatrists play an important role in the diagnosis and treatment of anti-NMDAR encephalitis. Recognizing the typical clinical progression and closely monitoring for accompanying neurologic symptoms will facilitate diagnosis and timely treatment. Careful selection of psychopharmacological interventions may reduce suffering.

Download full-text PDF

Source
May 2014

Publication Analysis

Top Keywords

anti-nmdar encephalitis
24
psychiatric symptoms
8
psychosis agitation
8
agitation insomnia
8
neurologic symptoms
8
diagnosis treatment
8
treatment strategies
8
anti-n-methyl-d-aspartate receptor
8
encephalitis
7
treatment
6
anti-nmdar
6
closely monitoring
4
provide clinical
4
authors conducted
4
reviewmethods authors
4
dystonia rigidity
4
progression closely
4
reports provide
4
context literature
4
clinical context
4

Keyword Occurance

Similar Publications

The challenge of diagnosing and successfully treating anti-NMDA receptor encephalitis in a toddler.

Authors:
Amal A Alqassmi Faisal Alaklabi Omar A Alzomor Mustafa A Salih

Sudan J Paediatr 2021 ;21(1):76-81

Division of Pediatric Neurology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis is an immune-mediated syndrome that is still under-recognised, with grave consequences if not treated early. A multidisciplinary team approach is required in the process of diagnosis and management of this potentially treatable and reversible disorder. We report on a 26-month-old Sudanese girl who presented with focal seizures associated with fever (temperature = 38. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Pediatric anti-NMDA receptor encephalitis associated with COVID-19.

Authors:
Esra Sarigecili Ilknur Arslan Habibe Koc Ucar Umit Celik

Childs Nerv Syst 2021 Apr 14. Epub 2021 Apr 14.

Department of Pediatric Infectious Diseases, Adana City Training and Research Hospital, Adana, Turkey.

Anti-N-methyl-D-aspartate receptor encephalitis is a clinical condition characterized by acute behavioral and mood changes, abnormal movements, autonomic instability, seizures, and encephalopathy. We describe a 7-year-old boy diagnosed with autoimmune encephalitis due to NMDAR antibody in association with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019) (COVID-19), without pulmonary involvement or fever. The patient presented with acute ataxia, rapidly developed encephalopathy, and autoimmune encephalitis was suspected. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Precocious puberty as a consequence of anti-NMDA receptor encephalitis in children.

Authors:
Po-Ming Wu Chao-Ku Teng Yen-Yin Chou Yi-Fang Tu

Pediatr Neonatol 2021 Mar 18. Epub 2021 Mar 18.

Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 70403, Taiwan; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan. Electronic address:

Background: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is one of the most common autoimmune encephalitis in children. Most children recovered well after anti-NMDA receptor encephalitis. However, the NMDA receptor network functions are critical for the developing brain in children. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers.

Authors:
Christian G Bien Cathrin Rohleder Juliane K Mueller Corinna I Bien Dagmar Koethe F Markus Leweke

Front Psychiatry 2021 26;12:654602. Epub 2021 Mar 26.

Brain and Mind Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

The pathophysiological role of neural autoantibodies in acute psychotic disorders is receiving increased attention. However, there is still an ongoing debate, whether predominantly psychotic manifestations of autoimmune encephalitides exist that may remain undetected and, thus, untreated. Furthermore, it is discussed if such conditions can be diagnosed based on serum antibody results or if a reliable diagnosis requires additional cerebrospinal fluids (CSF) results. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Variable response to Therapeutic plasma exchange in pediatric Anti-NMDA Receptor encephalitis.

Authors:
Archana Naik Satya Prakash Gopal Krushna Ray Amit Kumar Satpathy Somnath Mukherjee

Transfus Clin Biol 2021 Apr 8. Epub 2021 Apr 8.

Associate Professor, Department of Transfusion Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India. Electronic address:

Introduction: Anti-NMDA receptor encephalitis in an acute form generally presents with abnormal movements and psychiatric symptoms. Therapeutic plasma exchange has been considered to be one of the first line treatment options. This report highlights the role of plasma exchange in anti-NMDA receptor encephalitis in pediatric patients. Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap